YANG MICHAEL J. — SEC insider filings
SEC reporting owner CIK 1702283. 18 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2020-10-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 2,000 shares, $25,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 2,367 shares, $112,813 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 1,120 shares @ $53.34 ($59,741) in ACADIA PHARMACEUTICALS INC, filed 2021-01-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | EVP and CCO | 2 | — | 2 legs · 2,367 sh · $112,813 | 4 |
| Pacira BioSciences, Inc. (PCRX) | Director | 6 | 1 leg · 2,000 sh · $25,800 | — | 13 |
| IONIS PHARMACEUTICALS INC (IONS) | Director | 9 | — | — | 14 |
| AKCEA THERAPEUTICS, INC. (AKCA) | Director | 1 | — | — | 1 |
Insider filings — YANG MICHAEL J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Code (U): 13,393 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative) | EDGAR |
| 2026-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,930 @ $0 · Option exercise (M): 1,930 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,931 @ $0 · Option exercise (M): 1,931 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Pacira BioSciences, Inc. (PCRX) | Purchase (P): 2,000 @ $12.90 | EDGAR |
| 2024-07-03 | 4/A | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,111 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 5,791 (derivative) @ $0 | EDGAR |
| 2023-12-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 12,356 (derivative) @ $0 | EDGAR |
| 2023-10-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 30,967 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,722 · Sale (S): 1,120 @ $53.34 · Option exercise (M): 2,722 (derivative) @ $0 | EDGAR |
| 2020-10-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,500 · Sale (S): 1,247 @ $42.56 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | AKCEA THERAPEUTICS, INC. (AKCA) | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702283 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs